Metraipolis › archive › dc_a129b3984380

Clinical stabilization of a highly refractory acute myeloid leukaemia under individualized treatment with immune response modifying drugs by in vivo… — Europe PMC PMID:40817367

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40817367
DOI
10.1186/s40364-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-10T14:20:57.261Z
SHA-256 of the archived text
2f1ffe97471093a7e97534da8c99cb36e82a20a7847bcb3e1d007de88c584f13
Stable URL of this page
https://metraipolis.com/documento/dc_a129b3984380

How to cite

Clinical stabilization of a highly refractory acute myeloid leukaemia under individualized treatment with immune response modifying drugs by in vivo… — Europe PMC PMID:40817367 — Europe PMC (en), https://europepmc.org/article/MED/40817367 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a129b3984380 (Metraipolis archive dc_a129b3984380, sha256 2f1ffe97471093a7e97534da8c99cb36e82a20a7847bcb3e1d007de88c584f13)
BibTeX
@misc{dca129b3984380,
  title = {Clinical stabilization of a highly refractory acute myeloid leukaemia under individualized treatment with immune response modifying drugs by in vivo… — Europe PMC PMID:40817367},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40817367},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a129b3984380; sha256 2f1ffe97471093a7e97534da8c99cb36e82a20a7847bcb3e1d007de88c584f13},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40817367. Agents can read the archived copy with the MCP tool read_document.